awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37474602-085F326A-9B91-4596-A382-07E876113DA0
Q37474602-085F326A-9B91-4596-A382-07E876113DA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37474602-085F326A-9B91-4596-A382-07E876113DA0
New agents for AML and MDS.
P2860
Q37474602-085F326A-9B91-4596-A382-07E876113DA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37474602-085F326A-9B91-4596-A382-07E876113DA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d2964ecd7e763c6007763116a2f0310446cd9cc
P2860
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study